ArticlePloS one2025
Production of probiotic garden cress (Lepidium Sativum) using Bifidobacterium Bifidum and its evaluation of nutritional value, biocontrol and growth rate ability.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Innovative Iron-Fortified Synbiotic Drink From Yellow Spondias Dulcis L.: A Functional Beverage with Enhanced Nutritional and Antioxidant Properties.Probiotics and antimicrobial proteins · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Probiotics are one of the most beneficial elements in human health. Several studies have confirmed the health benefits of probiotics. The consumption of fermented vegetables is widespread worldwide and represents an important component of the human diet for a growing global population. In recent years, consumers have become more aware of the relationship between food and health, which has led to an increase in interest in functional foods. The global market for probiotic foods is growing rapidly due to the increasing consumer awareness. Although leafy vegetables are well-endowed with bacteria, including potentially probiotic strains of Lactobacillus, so far, plant-derived products have only been considered as carriers of probiotic cultures. This study aimed to produce probiotic garden cress using Bifidobacterium bifidum and to investigate its nutritional value, biocontrol, and growth rate and this is a great approach due to the increase in vegetarianism, lactose intolerance and people allergic to dairy products. Bifidobacterium bifidum (bb12) was inoculated into sterile cress seeds and the probiotic plant culture was done on days 0 and 3 after harvesting, in a TOS medium containing Mupirocin (MUP) antibiotic. The chemical properties (such as pH, acidity, and dry matter) of both samples were determined and the comparison of growth rate, fat content, vitamin C, and organoleptic properties was done. Bacterial survival in simulated gastrointestinal (SGI) conditions and its antifungal effect on Rhizoctonia solani were also analyzed. The number of bacteria on days 0 and 3 was [Formula: see text] and 2.3 [Formula: see text] Colony Forming Unit/gram (CFU/g) respectively, which confirms the probiotic nature of the product ([Formula: see text] bacteria). Also, significant difference ([Formula: see text]0.05) was observed in the physicochemical parameters. Bacterial viability was reported as 6.3 [Formula: see text] CFU/g in simulated gastric condition and as [Formula: see text] CFU/g in simulated intestine condition, and the antifungal effect of Bifidobacterium on R. solani was 15%. It can be concluded that production of other probiotic vegetables might be possible and that the plant based probiotics can be used to support the growth of human intestinal bacteria and also maintain high cell viability during storage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.